{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:43:03Z","timestamp":1787024583164,"version":"build-2736575974"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["201740174"],"award-info":[{"award-number":["201740174"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2019650"],"award-info":[{"award-number":["BE2019650"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20191032"],"award-info":[{"award-number":["BK20191032"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803430"],"award-info":[{"award-number":["81803430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702184"],"award-info":[{"award-number":["81702184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31700297"],"award-info":[{"award-number":["31700297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21807049"],"award-info":[{"award-number":["21807049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>L-type Calcium Channels (LTCCs), also termed as Ca&lt;sub&gt;v&lt;\/sub&gt;1, belong to voltage-gated calcium\nchannels (VGCCs\/Ca&lt;sub&gt;v&lt;\/sub&gt;s), which play a critical role in a wide spectrum of physiological processes, including\nneurotransmission, cell cycle, muscular contraction, cardiac action potential and gene expression.\nAberrant regulation of calcium channels is involved in neurological, cardiovascular, muscular and\npsychiatric disorders. Accordingly, LTCCs have been regarded as important drug targets, and a number\nof LTCC drugs are in clinical use. In this review, the recent development of structures and biological\nfunctions of LTCCs are introduced. Moreover, the representative modulators and ligand binding sites of\nLTCCs are discussed. Finally, molecular modeling and Computer-aided Drug Design (CADD) methods\nfor understanding structure-function relations of LTCCs are summarized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867327666200714154059","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T01:27:28Z","timestamp":1594776448000},"page":"514-524","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Advances in L-Type Calcium Channel Structures, Functions and Molecular Modeling"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4095-6539","authenticated-orcid":true,"given":"Lei","family":"Xu","sequence":"first","affiliation":[{"name":"Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5432-0128","authenticated-orcid":true,"given":"Lilei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weifang Second People's Hospital, Weifang 261041,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-5333","authenticated-orcid":true,"given":"Liangxu","family":"Xie","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-6055","authenticated-orcid":true,"given":"Shanzhi","family":"Mou","sequence":"additional","affiliation":[{"name":"School of Mathematics and Physics, Jiangsu University of Technology, Changzhou 213001,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5938-2603","authenticated-orcid":true,"given":"Dawei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-1765","authenticated-orcid":true,"given":"Jingyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Medicine and Pharmaceutics, Jiangnan University, Wuxi 214122,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0159-3640","authenticated-orcid":true,"given":"Peng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Second Military Medical University Affiliated Changzheng Hospital, Shanghai 200003,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2015.5","volume":"15","author":"Zamponi G.W.","year":"2016","unstructured":"Zamponi G.W.; Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat Rev Drug Discov 2016,15(1),19-34","journal-title":"Nat Rev Drug Discov"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"Catterall W.A.","year":"2011","unstructured":"Catterall W.A.; Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 2011,3(8)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuropharm.2016.10.016","volume":"127","author":"Bourinet E.","year":"2017","unstructured":"Bourinet E.; Zamponi G.W.; Block of voltage-gated calcium channels by peptide toxins. Neuropharmacology 2017,127,109-115","journal-title":"Neuropharmacology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","volume":"82","author":"Simms B.A.","year":"2014","unstructured":"Simms B.A.; Zamponi G.W.; Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron 2014,82(1),24-45","journal-title":"Neuron"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1007\/s12035-016-0045-6","volume":"54","author":"Vega-Vela N.E.","year":"2017","unstructured":"Vega-Vela N.E.; Osorio D.; Avila-Rodriguez M.; Gonzalez J.; Garc\u00eda-Segura L.M.; Echeverria V.; Barreto G.E.; L-type calcium channels modulation by estradiol. Mol Neurobiol 2017,54(7),4996-5007","journal-title":"Mol Neurobiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature12775","volume":"505","author":"Tang L.","year":"2014","unstructured":"Tang L.; El-Din T.M.G.; Payandeh J.; Martinez G.Q.; Heard T.M.; Scheuer T.; Zheng N.; Catterall W.A.; Structural basis for Ca2+ selectivity of a voltage-gated calcium channel. Nature 2014,505(7481),56-61","journal-title":"Nature"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature19102","volume":"537","author":"Tang L.","year":"2016","unstructured":"Tang L.; El-Din T.M.G.; Swanson T.M.; Pryde D.C.; Scheuer T.; Zheng N.; Catterall W.A.; Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs. Nature 2016,537(7618),117-121","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2395","volume":"350","author":"Wu J.","year":"2015","unstructured":"Wu J.; Yan Z.; Li Z.; Yan C.; Lu S.; Dong M.; Yan N.; Structure of the voltage-gated calcium channel Cav1.1 complex. Science 2015,350(6267)","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature19321","volume":"537","author":"Wu J.","year":"2016","unstructured":"Wu J.; Yan Z.; Li Z.; Qian X.; Lu S.; Dong M.; Zhou Q.; Yan N.; Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6\u2009\u00c5 resolution. Nature 2016,537(7619),191-196","journal-title":"Nature"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1495.e12","DOI":"10.1016\/j.cell.2019.04.043","volume":"177","author":"Zhao Y.","year":"2019","unstructured":"Zhao Y.; Huang G.; Wu J.; Wu Q.; Gao S.; Yan Z.; Lei J.; Yan N.; Molecular basis for ligand modulation of a mammalian voltage-gated Ca2+ channel. Cell 2019,177(6),1495.e12-1506.e12","journal-title":"Cell"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"Catterall W.A.","year":"2005","unstructured":"Catterall W.A.; Perez-Reyes E.; Snutch T.P.; Striessnig J.; International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 2005,57(4),411-425","journal-title":"Pharmacol Rev"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52828","volume":"9","author":"Shimomura T.","year":"2020","unstructured":"Shimomura T.; Yonekawa Y.; Nagura H.; Tateyama M.; Fujiyoshi Y.; Irie K.; A native prokaryotic voltage-dependent calcium channel with a novel selectivity filter sequence. eLife 2020,9","journal-title":"eLife"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wmts.102","volume":"3","author":"Striessnig J.","year":"2014","unstructured":"Striessnig J.; Pinggera A.; Kaur G.; Bock G.; Tuluc P.; L-type Ca2+ channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal 2014,3(2),15-38","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1085\/jgp.201210873","volume":"140","author":"Vargas E.","year":"2012","unstructured":"Vargas E.; Yarov-Yarovoy V.; Khalili-Araghi F.; Catterall W.A.; Klein M.L.; Tarek M.; Lindahl E.; Schulten K.; Perozo E.; Bezanilla F.; Roux B.; An emerging consensus on voltage-dependent gating from computational modeling and molecular dynamics simulations. J Gen Physiol 2012,140(6),587-594","journal-title":"J Gen Physiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00424-018-2163-7","volume":"470","author":"Hering S.","year":"2018","unstructured":"Hering S.; Zangerl-Plessl E-M.; Beyl S.; Hohaus A.; Andranovits S.; Timin E.N.; Calcium channel gating. Pflugers Arch 2018,470(9),1291-1309","journal-title":"Pflugers Arch"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pharmtox-010818-021757","volume":"60","author":"Catterall W.A.","year":"2020","unstructured":"Catterall W.A.; Lenaeus M.J.; El-Din T.M.G.; Structure and pharmacology of voltage-gated sodium and calcium channels. Annu Rev Pharmacol Toxicol 2020,60,133-154","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1085\/jgp.109.4.449","volume":"109","author":"Ferreira G.","year":"1997","unstructured":"Ferreira G.; Yi J.; R\u00edos E.; Shirokov R.; Ion-dependent inactivation of barium current through L-type calcium channels. J Gen Physiol 1997,109(4),449-461","journal-title":"J Gen Physiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00415-006-0339-0","volume":"253","author":"Jurkat-Rott K.","year":"2006","unstructured":"Jurkat-Rott K.; Lehmann-Horn F.; Paroxysmal muscle weakness: the familial periodic paralyses. J Neurol 2006,253(11),1391-1398","journal-title":"J Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"Robinson R.","year":"2006","unstructured":"Robinson R.; Carpenter D.; Shaw M.A.; Halsall J.; Hopkins P.; Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006,27(10),977-989","journal-title":"Hum Mutat"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/19336950.2015.1048936","volume":"10","author":"Ortner N.J.","year":"2016","unstructured":"Ortner N.J.; Striessnig J.; L-type calcium channels as drug targets in CNS disorders. Channels (Austin) 2016,10(1),7-13","journal-title":"Channels (Austin)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2174\/1570159X11311060005","volume":"11","author":"Lee S.","year":"2013","unstructured":"Lee S.; Pharmacological inhibition of voltage-gated Ca(2+) channels for chronic pain relief. Curr Neuropharmacol 2013,11(6),606-620","journal-title":"Curr Neuropharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2017.00286","volume":"8","author":"Godfraind T.","year":"2017","unstructured":"Godfraind T.; Discovery and development of calcium channel blockers. Front Pharmacol 2017,8,286","journal-title":"Front Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874467208666150507105845","volume":"8","author":"Striessnig J.","year":"2015","unstructured":"Striessnig J.; Ortner N.J.; Pinggera A.; Pharmacology of L-type calcium channels: novel drugs for old targets? Curr Mol Pharmacol 2015,8(2),110-122","journal-title":"Curr Mol Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.2174\/092986712802884204","volume":"19","author":"Carosati E.","year":"2012","unstructured":"Carosati E.; Ioan P.; Micucci M.; Broccatelli F.; Cruciani G.; Zhorov B.S.; Chiarini A.; Budriesi R.; 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets. Curr Med Chem 2012,19(25),4306-4323","journal-title":"Curr Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.drudis.2009.08.004","volume":"14","author":"Edraki N.","year":"2009","unstructured":"Edraki N.; Mehdipour A.R.; Khoshneviszadeh M.; Miri R.; Dihydropyridines: evaluation of their current and future pharmacological applications. Drug Discov Today 2009,14(21-22),1058-1066","journal-title":"Drug Discov Today"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"22100","DOI":"10.1074\/jbc.M101469200","volume":"276","author":"Koschak A.","year":"2001","unstructured":"Koschak A.; Reimer D.; Huber I.; Grabner M.; Glossmann H.; Engel J.; Striessnig J.; Alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem 2001,276(25),22100-22106","journal-title":"J Biol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ncomms2149","volume":"3","author":"Kang S.","year":"2012","unstructured":"Kang S.; Cooper G.; Dunne S.F.; Dusel B.; Luan C.H.; Surmeier D.J.; Silverman R.B.; CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson\u2019s disease. Nat Commun 2012,3(1),1146","journal-title":"Nat Commun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1016\/j.bmc.2013.04.054","volume":"21","author":"Kang S.","year":"2013","unstructured":"Kang S.; Cooper G.; Dunne S.F.; Luan C.H.; James Surmeier D.; Silverman R.B.; Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics. Bioorg Med Chem 2013,21(14),4365-4373","journal-title":"Bioorg Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0014-2999(85)90631-4","volume":"114","author":"Franckowiak G.","year":"1985","unstructured":"Franckowiak G.; Bechem M.; Schramm M.; Thomas G.; The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. Eur J Pharmacol 1985,114(2),223-226","journal-title":"Eur J Pharmacol"},{"key":"ref=30","first-page":"69","volume":"9","author":"Vo D.","year":"1992","unstructured":"Vo D.; Wolowyk M.W.; Knaus E.E.; Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines. Drug Des Discov 1992,9(1),69-78","journal-title":"Drug Des Discov"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/anie.199115591","volume":"30","author":"Goldmann S.","year":"1991","unstructured":"Goldmann S.; Stoltefuss J.; 1,4-dihydropyridines: effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew Chem Int Ed Engl 1991,30(12),1559-1578","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/mol.119.117531","volume":"96","author":"Tang L.","year":"2019","unstructured":"Tang L.; El-Din T.M.G.; Lenaeus M.J.; Zheng N.; Catterall W.A.; Structural basis for diltiazem block of a voltage-gated Ca2+ channel. Mol Pharmacol 2019,96(4),485-492","journal-title":"Mol Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3797\/scipharm.1101-19","volume":"79","author":"Srinivasan V.","year":"2011","unstructured":"Srinivasan V.; Sivaramakrishnan H.; Karthikeyan B.; Detection, isolation and characterization of principal synthetic route indicative impurities in verapamil hydrochloride. Sci Pharm 2011,79(3),555-568","journal-title":"Sci Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.phrs.2018.11.017","volume":"139","author":"Li W.","year":"2019","unstructured":"Li W.; Shi G.; How CaV1.2-bound verapamil blocks Ca2+ influx into cardiomyocyte: atomic level views. Pharmacol Res 2019,139,153-157","journal-title":"Pharmacol Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuropharm.2017.06.030","volume":"132","author":"Musgaard M.","year":"2018","unstructured":"Musgaard M.; Paramo T.; Domicevica L.; Andersen O.J.; Biggin P.C.; Insights into channel dysfunction from modelling and molecular dynamics simulations. Neuropharmacology 2018,132,20-30","journal-title":"Neuropharmacology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.280.5360.69","volume":"280","author":"Doyle D.A.","year":"1998","unstructured":"Doyle D.A.; Morais Cabral J.; Pfuetzner R.A.; Kuo A.; Gulbis J.M.; Cohen S.L.; Chait B.T.; MacKinnon R.; The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 1998,280(5360),69-77","journal-title":"Science"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/abbi.2001.2484","volume":"393","author":"Zhorov B.S.","year":"2001","unstructured":"Zhorov B.S.; Folkman E.V.; Ananthanarayanan V.S.; Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists. Arch Biochem Biophys 2001,393(1),22-41","journal-title":"Arch Biochem Biophys"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1039\/C5MB00781J","volume":"12","author":"Xu L.","year":"2016","unstructured":"Xu L.; Li D.; Tao L.; Yang Y.; Li Y.; Hou T.; Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study. Mol Biosyst 2016,12(2),379-390","journal-title":"Mol Biosyst"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"19006","DOI":"10.1074\/jbc.M109.011296","volume":"284","author":"Tikhonov D.B.","year":"2009","unstructured":"Tikhonov D.B.; Zhorov B.S.; Structural model for dihydropyridine binding to L-type calcium channels. J Biol Chem 2009,284(28),19006-19017","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bpj.2017.08.010","volume":"113","author":"Monteleone S.","year":"2017","unstructured":"Monteleone S.; Lieb A.; Pinggera A.; Negro G.; Fuchs J.E.; Hofer F.; Striessnig J.; Tuluc P.; Liedl K.R.; Mechanisms responsible for \u03c9-pore currents in Cav calcium channel voltage-sensing domains. Biophys J 2017,113(7),1485-1495","journal-title":"Biophys J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbagen.2019.04.006","volume":"1863","author":"Feng T.","year":"2019","unstructured":"Feng T.; Kalyaanamoorthy S.; Ganesan A.; Barakat K.; Atomistic modeling and molecular dynamics analysis of human CaV1.2 channel using external electric field and ion pulling simulations. Biochim Biophys Acta, Gen Subj 2019,1863(6),1116-1126","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1021\/jm0604373","volume":"49","author":"Carosati E.","year":"2006","unstructured":"Carosati E.; Cruciani G.; Chiarini A.; Budriesi R.; Ioan P.; Spisani R.; Spinelli D.; Cosimelli B.; Fusi F.; Frosini M.; Matucci R.; Gasparrini F.; Ciogli A.; Stephens P.J.; Devlin F.J.; Calcium channel antagonists discovered by a multidisciplinary approach. J Med Chem 2006,49(17),5206-5216","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/ci600253e","volume":"47","author":"Baroni M.","year":"2007","unstructured":"Baroni M.; Cruciani G.; Sciabola S.; Perruccio F.; Mason J.S.; A common reference framework for analyzing\/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application. J Chem Inf Model 2007,47(2),279-294","journal-title":"J Chem Inf Model"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1021\/jm800151n","volume":"51","author":"Carosati E.","year":"2008","unstructured":"Carosati E.; Budriesi R.; Ioan P.; Ugenti M.P.; Frosini M.; Fusi F.; Corda G.; Cosimelli B.; Spinelli D.; Chiarini A.; Cruciani G.; Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening. J Med Chem 2008,51(18),5552-5565","journal-title":"J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1021\/jm061259g","volume":"50","author":"Bergmann R.","year":"2007","unstructured":"Bergmann R.; Linusson A.; Zamora I.; SHOP: scaffold hopping by GRID-based similarity searches. J Med Chem 2007,50(11),2708-2717","journal-title":"J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Shoichet B.K.; ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005,45(1),177-182","journal-title":"J Chem Inf Model"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200714154059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183766\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200714154059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:34:05Z","timestamp":1660055645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183766\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666200714154059","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}